Calidi Biotherapeutics
CLDI • AMEX
Calidi Biotherapeutics is a biotechnology company in the healthcare sector trading on AMEX, led by CEO Eric E. Poma, with a market cap of $6.0M.
CEOEric E. Poma
Market Cap$6.0M
Biotechnology
Healthcare
Employees41.0
Websitecalidibio.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Calidi Biotherapeutics
Date
Monday, March 30, 2026 (in 2 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q4 2025
EPS Estimate
-$1.56
Earnings History
Past 9 earnings reports for Calidi Biotherapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2025 | Q3 2025 | -$2.21Est: -$1.68 | -31.5% | - | — |  10-Q |
| Aug 8, 2025 | Q2 2025 | -$1.99Est: -$1.32 | -50.8% | - | — | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.18 | — | - | — | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$0.27 | — | - | — | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.65Est: -$0.85 | +23.5% | - | — | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$1.40Est: -$2.20 | +36.4% | - | — | 10-Q |
| May 14, 2024 | Q1 2024 | -$2.00Est: -$2.70 | +25.9% | - | — | 10-Q |
| Mar 15, 2024 | Q4 2023 | -$2.30Est: -$2.00 | -15.0% | - | — | 10-K |
| Nov 14, 2023 | Q3 2023 | -$1.40 | — | - | — | — |